Viewing Study NCT05630859


Ignite Creation Date: 2025-12-24 @ 2:31 PM
Ignite Modification Date: 2026-04-29 @ 12:07 AM
Study NCT ID: NCT05630859
Status: COMPLETED
Last Update Posted: 2025-08-07
First Post: 2022-11-25
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety and Efficacy of GSK Neisseria Gonorrhoeae GMMA (NgG) Investigational Vaccine When Administered to Healthy Adults 18 to 50 Years of Age.
Sponsor: GlaxoSmithKline
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Sexually Transmitted Diseases View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Neisseria gonorrhoeae View
None Safety View
None Efficacy View
None Sexually transmitted infection View
None Healthy adults 18 to 50 years of age View